326 related articles for article (PubMed ID: 4064843)
41. Measurement of the S-phase duration in normal and abnormal human endometrium by in vitro double labelling with bromodeoxyuridine and tritiated thymidine.
Thornton JG; Wells M; Hume WJ
J Pathol; 1989 Feb; 157(2):109-15. PubMed ID: 2921671
[TBL] [Abstract][Full Text] [Related]
42. Pan cycle expression of proliferating cell nuclear antigen in human colorectal cancer and its proliferative correlations.
Sawtell RM; Rew DA; Stradling RN; Wilson GD
Cytometry; 1995 Sep; 22(3):190-9. PubMed ID: 8556950
[TBL] [Abstract][Full Text] [Related]
43. Measurement of DNA ploidy and proliferation rate in lung tumours by bromodeoxyuridine labelling index, S-phase fraction and AgNOR technique.
Gasińska A; Biesaga B; Kołodziejski L; Słonina D
Pol J Pathol; 1996; 47(4):201-7. PubMed ID: 9097713
[TBL] [Abstract][Full Text] [Related]
44. Effect of 5-fluoro-2'-deoxyuridine (FdUrd) on 5-bromo-2'-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect.
Ellwart J; Dörmer P
Cytometry; 1985 Nov; 6(6):513-20. PubMed ID: 2415309
[TBL] [Abstract][Full Text] [Related]
45. Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics.
Dolbeare F
Histochem J; 1995 May; 27(5):339-69. PubMed ID: 7657555
[TBL] [Abstract][Full Text] [Related]
46. Cell cycle analysis by combining the 5-bromodeoxyuridine/33258 Hoechst technique with DNA-specific ethidium bromide staining.
Böhmer RM; Ellwart J
Cytometry; 1981 Jul; 2(1):31-4. PubMed ID: 6168457
[TBL] [Abstract][Full Text] [Related]
47. Rapid in vitro bromodeoxyuridine labeling method for monitoring of therapy response in solid human tumors.
Hemmer J
Cytometry; 1990; 11(5):603-9. PubMed ID: 2379451
[TBL] [Abstract][Full Text] [Related]
48. Flow cytometry after bromodeoxyuridine labeling to measure S and G2+M phase durations plus doubling times in vitro and in vivo.
Terry NH; White RA
Nat Protoc; 2006; 1(2):859-69. PubMed ID: 17406318
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the classical autoradiographic and the immunohistochemical methods with BrdU for measuring proliferation parameters in colon cancer.
Qin Y; Willems G
Anticancer Res; 1993; 13(3):731-5. PubMed ID: 8317905
[TBL] [Abstract][Full Text] [Related]
50. Application of an ELISA procedure for the quantitation of bromodeoxyuridine incorporated into cellular DNA.
Cheitlin RA; Bodell WJ
Anticancer Res; 1988; 8(3):471-4. PubMed ID: 3389750
[TBL] [Abstract][Full Text] [Related]
51. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody].
Sasaki K; Murakami T; Ogino T; Takahashi M
Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667
[TBL] [Abstract][Full Text] [Related]
52. BrdUrd incorporation studies for evaluation of spermatogenesis in the blue fox.
Clausen OP; Berg KA; Kirkhus B; De Angelis P; Huitfeldt H
Cytometry; 1992; 13(4):374-80. PubMed ID: 1526196
[TBL] [Abstract][Full Text] [Related]
53. An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry.
Schutte B; Reynders MM; van Assche CL; Hupperets PS; Bosman FT; Blijham GH
Cytometry; 1987 Jul; 8(4):372-6. PubMed ID: 3113895
[TBL] [Abstract][Full Text] [Related]
54. Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrd-labelling index under different proliferative conditions in vitro by flow cytometry.
Lohr F; Wenz F; Haas S; Flentje M
Cell Prolif; 1995 Feb; 28(2):93-104. PubMed ID: 7893842
[TBL] [Abstract][Full Text] [Related]
55. Dividing cells in bone marrow and spleen incorporate bromodeoxyuridine with high efficiency.
Schittek B; Rajewsky K; Förster I
Eur J Immunol; 1991 Jan; 21(1):235-8. PubMed ID: 1991489
[TBL] [Abstract][Full Text] [Related]
56. Cell cycle kinetic measurements in an irradiated rat rhabdomyosarcoma using a monoclonal antibody to bromodeoxyuridine.
Nüsse M; Afzal SM; Carr B; Kavanau K
Cytometry; 1985 Nov; 6(6):611-9. PubMed ID: 4064841
[TBL] [Abstract][Full Text] [Related]
57. S-phase arrest of nutrient deprived lung cancer cells.
Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
[TBL] [Abstract][Full Text] [Related]
58. Cell proliferation kinetics of six xenografted human cervix carcinomas: comparison of autoradiography and bromodeoxyuridine labelling methods.
van Oostrum IE; Rozemuller E; Knol RF; Erkens-Schulze S; Rutgers DH
Cell Tissue Kinet; 1990 Nov; 23(6):523-44. PubMed ID: 2276171
[TBL] [Abstract][Full Text] [Related]
59. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
60. Labelling indices in human tumours: to apply corrections or not--that is the question.
Bergström C; Begg A; Palmqvist R; Waites A; Denekamp J
Br J Cancer; 1999 Jul; 80(10):1635-43. PubMed ID: 10408411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
